Drugs / DA-5218-R2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05449704 | Jul → Sep 2022 | — | Dong-A ST Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5218-R2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05449704 ↗ |